This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2003 Dec:92 Suppl 2:97-100.

doi: 10.1111/j.1464-410x.2003.04407.x.

Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening

S Ciatto¹, M Zappa, A Villers, A Paez, S J Otto, A Auvinen

Affiliations

PMID: 14983964
DOI: 10.1111/j.1464-410x.2003.04407.x

Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening

S Ciatto et al. BJU Int. 2003 Dec.

. 2003 Dec:92 Suppl 2:97-100.

doi: 10.1111/j.1464-410x.2003.04407.x.

Authors

S Ciatto¹, M Zappa, A Villers, A Paez, S J Otto, A Auvinen

Affiliation

¹ Department Diagnostic Medical Imaging, Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy. s.ciatto@cspo.it

PMID: 14983964
DOI: 10.1111/j.1464-410x.2003.04407.x

No abstract available

PubMed Disclaimer

Similar articles

Monitoring the ERSPC trial.
De Koning HJ, Hakulinen T, Moss SM, Adolfsson J, Smith PH, Alexander FE; ERSPC. De Koning HJ, et al. BJU Int. 2003 Dec;92 Suppl 2:112-4. doi: 10.1111/j.1464-410x.2003.4410x.x. BJU Int. 2003. PMID: 14983967 No abstract available.
The ERSPC Quality Control Committee.
Ciatto S. Ciatto S. BJU Int. 2003 Dec;92 Suppl 2:57-61. doi: 10.1111/j.1465-5101.2003.04399.x. BJU Int. 2003. PMID: 14983957 No abstract available.
Prostate cancer: estimating the benefits of PSA screening.
Vickers AJ, Lilja H. Vickers AJ, et al. Nat Rev Urol. 2009 Jun;6(6):301-3. doi: 10.1038/nrurol.2009.95. Nat Rev Urol. 2009. PMID: 19498406 Free PMC article.
Prostate cancer screening.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2008 Nov 3;50(1298):85-6. Med Lett Drugs Ther. 2008. PMID: 18978703 Review. No abstract available.
No randomised trial of prostate-cancer screening in Norway.
Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L; Norwegian Urological Cancer Group. Fosså SD, et al. Lancet Oncol. 2001 Dec;2(12):741-5; discussion 746-9. doi: 10.1016/S1470-2045(01)00588-5. Lancet Oncol. 2001. PMID: 11902516 Review.

See all similar articles

Cited by

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.
de Koning HJ, Gulati R, Moss SM, Hugosson J, Pinsky PF, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, de Carvalho TM, Feuer EJ, Tsodikov A, Mariotto AB, Heijnsdijk EAM, Etzioni R. de Koning HJ, et al. Cancer. 2018 Mar 15;124(6):1197-1206. doi: 10.1002/cncr.31178. Epub 2017 Dec 6. Cancer. 2018. PMID: 29211316 Free PMC article.
Prostate-cancer mortality at 11 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135. N Engl J Med. 2012. PMID: 22417251 Free PMC article. Clinical Trial.
Impact of cause of death adjudication on the results of the European prostate cancer screening trial.
Walter SD, de Koning HJ, Hugosson J, Talala K, Roobol MJ, Carlsson S, Zappa M, Nelen V, Kwiatkowski M, Páez Á, Moss S, Auvinen A; ERSPC Cause of Death Committees. Walter SD, et al. Br J Cancer. 2017 Jan 3;116(1):141-148. doi: 10.1038/bjc.2016.378. Epub 2016 Nov 17. Br J Cancer. 2017. PMID: 27855442 Free PMC article.
Rationale for statins in the chemoprevention of prostate cancer.
Hamilton RJ, Freedland SJ. Hamilton RJ, et al. Curr Urol Rep. 2008 May;9(3):189-96. doi: 10.1007/s11934-008-0034-z. Curr Urol Rep. 2008. PMID: 18765112 Review.
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
Pron G. Pron G. Ont Health Technol Assess Ser. 2015 May 1;15(10):1-64. eCollection 2015. Ont Health Technol Assess Ser. 2015. PMID: 26366236 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information